Publications by authors named "Amer Assal"

23Publications

Extended letermovir administration, beyond day 100, is effective for CMV prophylaxis in patients with graft versus host disease.

Transpl Infect Dis 2020 Oct 9:e13487. Epub 2020 Oct 9.

Division of Hematology/Oncology, Department of Internal Medicine, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tid.13487DOI Listing
October 2020

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

Blood Adv 2020 Jul;4(13):3180-3190

Center for International Blood and Marrow Transplant Research, Department of Medicine, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019001266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362362PMC
July 2020

Rewriting the rules for care of MDS and AML patients in the time of COVID-19.

Leuk Res Rep 2020 20;13:100201. Epub 2020 Apr 20.

Division of Hematology/Oncology, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lrr.2020.100201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169905PMC
April 2020

Case Report: Carfilzomib-induced Thrombotic Microangiopathy With Complement Activation Treated Successfully With Eculizumab.

Clin Lymphoma Myeloma Leuk 2020 04 4;20(4):e155-e157. Epub 2020 Feb 4.

Division of Hematology and Oncology, Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.01.016DOI Listing
April 2020

Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma.

Blood Cancer J 2020 02 3;10(2):13. Epub 2020 Feb 3.

Division of Hematology/Oncology, Columbia University Irving Medical Center, 161 Fort Washington Ave, New York, NY, 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-020-0278-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997347PMC
February 2020

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Haematologica 2020 05 26;105(5):1329-1338. Epub 2019 Sep 26.

Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.220756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193485PMC
May 2020

Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1-Negative Human Lung Cancers.

Clin Cancer Res 2018 04 26;24(8):1954-1964. Epub 2018 Jan 26.

Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-2924DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899616PMC
April 2018

Risk factors and prognosis of ovarian vein thrombosis.

Blood Coagul Fibrinolysis 2017 Sep;28(6):468-474

aDivision of Hematology, Department of Oncology bDepartment of Medicine cDepartment of Epidemiology and Population Health, Montefiore Medical Center, Albert Einstein College of Medicine, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0000000000000623DOI Listing
September 2017

Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.

Immunotherapy 2015 16;7(11):1169-86. Epub 2015 Nov 16.

Department of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.15.78DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976877PMC
September 2016

Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway.

Trends Mol Med 2015 Jan 30;21(1):24-33. Epub 2014 Oct 30.

Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY 10461, USA; Department of Oncology, Montefiore Medical Center, New York, NY 10467, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molmed.2014.10.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282825PMC
January 2015

In-stent thrombosis following DDAVP administration: case report and review of the literature.

Blood Coagul Fibrinolysis 2014 Jan;25(1):81-3

aLeon H. Charney Divison of Cardiology, Department of Medicine, New York University Langone School of Medicine bDepartment of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0b013e328364c232DOI Listing
January 2014